ProKidney (PROK) News Today → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free PROK Stock Alerts $3.19 -0.41 (-11.39%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 6:42 AM | americanbankingnews.comProKidney (NASDAQ:PROK) Stock Price Down 9.2%June 7 at 2:45 PM | marketbeat.comProKidney (NASDAQ:PROK) Trading Down 9.2%ProKidney (NASDAQ:PROK) Stock Price Down 9.2%June 4, 2024 | americanbankingnews.comComparing ProKidney (NASDAQ:PROK) & Beam Therapeutics (NASDAQ:BEAM)June 3, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading Up 10.6%ProKidney (NASDAQ:PROK) Stock Price Up 10.6%May 31, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading Down 6.2%ProKidney (NASDAQ:PROK) Stock Price Down 6.2%May 30, 2024 | americanbankingnews.comProKidney (NASDAQ:PROK) Trading Up 4.7%May 30, 2024 | americanbankingnews.comProKidney (NASDAQ:PROK) Given New $4.00 Price Target at Bank of AmericaMay 29, 2024 | marketbeat.comBank of America Raises ProKidney (NASDAQ:PROK) Price Target to $4.00Bank of America raised their target price on shares of ProKidney from $3.00 to $4.00 and gave the company a "neutral" rating in a report on Wednesday.May 29, 2024 | globenewswire.comProKidney to Participate in the Jefferies Global Healthcare ConferenceMay 29, 2024 | markets.businessinsider.comBuy Rating Affirmed for ProKidney on Rilparencel’s Promising Efficacy in CKD TreatmentMay 23, 2024 | insidertrades.comInsider Selling: ProKidney Corp. (NASDAQ:PROK) Insider Sells 17,238 Shares of StockMay 23, 2024 | seekingalpha.comProKidney: Date Due In Several Days May Enhance Bull Thesis, But I'm SkepticalMay 22, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) Insider Sells $70,331.04 in StockProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Darin J. Weber sold 17,238 shares of the stock in a transaction on Monday, May 20th. The shares were sold at an average price of $4.08, for a total value of $70,331.04. Following the completion of the sale, the insider now owns 137,956 shares in the company, valued at approximately $562,860.48. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.May 21, 2024 | globenewswire.comProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024May 20, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Up 4.2%ProKidney (NASDAQ:PROK) Stock Price Up 4.2%May 17, 2024 | insidertrades.comProKidney Corp. (NASDAQ:PROK) Insider Buys $19,600.00 in StockMay 16, 2024 | marketbeat.comControl Empresarial De Capital Buys 14,000 Shares of ProKidney Corp. (NASDAQ:PROK) StockProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Control Empresarial De Capital acquired 14,000 shares of the firm's stock in a transaction on Friday, March 22nd. The stock was purchased at an average price of $1.40 per share, with a total value of $19,600.00. Following the purchase, the insider now owns 63,265,645 shares in the company, valued at approximately $88,571,903. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.May 16, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 4.1% ProKidney (NASDAQ:PROK) Trading Down 4.1%May 15, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Down to $4.12ProKidney (NASDAQ:PROK) Shares Gap Down to $4.12May 14, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Up 9.4%ProKidney (NASDAQ:PROK) Stock Price Up 9.4%May 13, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Up to $2.81ProKidney (NASDAQ:PROK) Shares Gap Up to $2.81May 11, 2024 | finance.yahoo.comWe're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash WiselyMay 10, 2024 | finance.yahoo.comProKidney Corp Reports First Quarter 2024 Financial ResultsMay 10, 2024 | investorplace.comPROK Stock Earnings: ProKidney Beats EPS for Q1 2024May 10, 2024 | globenewswire.comProKidney Reports Business Updates and First Quarter 2024 Financial ResultsMay 7, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading Up 5.8%ProKidney (NASDAQ:PROK) Trading 5.8% HigherApril 29, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Up 6.1%ProKidney (NASDAQ:PROK) Stock Price Up 6.1%April 28, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) Sees Large Drop in Short InterestProKidney Corp. (NASDAQ:PROK - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 11,560,000 shares, a drop of 17.3% from the March 31st total of 13,980,000 shares. Based on an average daily volume of 702,200 shares, the short-interest ratio is presently 16.5 days. Currently, 26.7% of the company's stock are sold short.April 26, 2024 | finance.yahoo.comDiabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032April 25, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Down 7.4%ProKidney (NASDAQ:PROK) Shares Down 7.4%April 24, 2024 | insidertrades.comInsider Selling: ProKidney Corp. (NASDAQ:PROK) SVP Sells 16,438 Shares of StockApril 22, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Sees Large Volume IncreaseProKidney (NASDAQ:PROK) Sees Strong Trading VolumeApril 20, 2024 | finance.yahoo.comPROK Apr 2024 5.000 putApril 19, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 2.5% ProKidney (NASDAQ:PROK) Trading Down 2.5%April 19, 2024 | insidertrades.comDarin J. Weber Sells 17,238 Shares of ProKidney Corp. (NASDAQ:PROK) StockApril 18, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Down Following Insider SellingProKidney (NASDAQ:PROK) Shares Gap Down on Insider SellingApril 17, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) SVP Darin J. Weber Sells 17,238 SharesProKidney Corp. (NASDAQ:PROK - Get Free Report) SVP Darin J. Weber sold 17,238 shares of ProKidney stock in a transaction that occurred on Tuesday, April 16th. The stock was sold at an average price of $2.50, for a total value of $43,095.00. Following the transaction, the senior vice president now owns 172,432 shares of the company's stock, valued at $431,080. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.April 17, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Up to $2.72ProKidney (NASDAQ:PROK) Shares Gap Up to $2.72March 26, 2024 | bizjournals.comDuring manufacturing pause, ProKidney increases R&D spending to $106.7MMarch 25, 2024 | globenewswire.comProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical OperationsMarch 24, 2024 | markets.businessinsider.comBuy Rating Affirmed for ProKidney Amidst Strategic Clinical Advancements and Solid Financial OutlookMarch 21, 2024 | globenewswire.comProKidney Reports Full Year 2023 Financial Results and Recent Corporate HighlightsMarch 21, 2024 | marketbeat.comProKidney (PROK) to Release Earnings on FridayProKidney (NASDAQ:PROK) will be releasing earnings on Friday, March 22, Yahoo Finance reports.March 7, 2024 | realmoney.thestreet.comProKidney assumed with an Equal Weight at Morgan StanleyMarch 7, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Earns Equal Weight Rating from Morgan StanleyMorgan Stanley reaffirmed an "equal weight" rating and set a $3.00 price target on shares of ProKidney in a research report on Thursday.March 3, 2024 | marketbeat.comProKidney (PROK) Set to Announce Earnings on MondayProKidney (NASDAQ:PROK) will be releasing earnings on Monday, March 4, Yahoo Finance reports.February 29, 2024 | globenewswire.comProKidney to Participate in Jefferies Biotech on the Bay SummitFebruary 17, 2024 | finance.yahoo.comPROK Mar 2024 7.500 callFebruary 16, 2024 | bizjournals.comNorth Carolina biotech tops $400M in funding for asthma treatmentFebruary 9, 2024 | fool.comProKidney (NASDAQ: PROK) Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 AI Stocks to Buy for 2024 (Ad)The electric vehicle boom is accelerating – and fast. Click to View The 5 Best AI Stocks to Invest In PROK Media Mentions By Week PROK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PROK News Sentiment▼0.000.75▲Average Medical News Sentiment PROK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PROK Articles This Week▼32▲PROK Articles Average Week Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LGST News AKLI News GETR News SWTX News ACLX News APGE News DNLI News IOVA News IMCR News TWST News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PROK) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored